BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
jubilant pharmova ltd stock

JUBILANT PHARMOVA LTD Share Price

1227.1 0.44 (0.03%)
Dec 04 2024 03:30 PM Pharmaceuticals NSE: JUBLPHARMA

JUBILANT PHARMOVA LTD Share Price Update

As of the latest trading session, JUBILANT PHARMOVA LTD share price is currently at 1227.1, which is up by 0.44 from its previous closing. Today, the stock has fluctuated between 1210.25 and 1265.00. Over the past year, JUBILANT PHARMOVA LTD has achieved a return of 160.93 %. In the last month alone, the return has been -2.06 %. Read More...

JUBILANT PHARMOVA LTD Performance

Day Range

Low1210.25 High1265.00
1227.10

52 Week Range

Low 450.80 High 1309.90
1227.10

JUBILANT PHARMOVA LTD Share Price

3637

530019

JUBLPHARMA

img img img img
No Data Available

Open Price

1215.50

Prev. Close

1226.65

Volume (Shares)

248351.00

Total traded value

3047.51

Upper Circuit

1471.95

Lower Circuit

981.35

Note: The current prices & values are delayed, Login to your account for live updates.

JUBILANT PHARMOVA LTD Fundamentals


(Standalone)

Market Cap (Cr) 19431.22
PE Ratio (TTM) 642.15
Book Value / Share 144.29
Beta 0.85
ROE 1.32%
EPS (TTM) 2.61
Dividend Yield 0.41%
Net Profit Qtr (Cr) 10.50

JUBILANT PHARMOVA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 162.60
Operating Expense 192.90
Net Profit 10.50
Net Profit Margin (%) 6.45
Earnings Per Share (EPS) 0.66
EBITDA 37.70
Effective Tax Rate (%) 36.74
Particulars JUN 2024 (Values in Cr)
Revenue 162.70
Operating Expense 186.20
Net Profit -10.20
Net Profit Margin (%) -6.26
Earnings Per Share (EPS) -0.64
EBITDA 9.50
Effective Tax Rate (%) 8.92
Particulars MAR 2024 (Values in Cr)
Revenue 201.70
Operating Expense 214.40
Net Profit 32.50
Net Profit Margin (%) 16.11
Earnings Per Share (EPS) 2.05
EBITDA 62.30
Effective Tax Rate (%) 21.68
Particulars DEC 2023 (Values in Cr)
Revenue 170.20
Operating Expense 196.50
Net Profit -2.40
Net Profit Margin (%) -1.41
Earnings Per Share (EPS) -0.15
EBITDA 18.30
Effective Tax Rate (%) -4.34
Particulars SEP 2023 (Values in Cr)
Revenue 179.40
Operating Expense 204.50
Net Profit -0.40
Net Profit Margin (%) -0.22
Earnings Per Share (EPS) -0.03
EBITDA 19.20
Effective Tax Rate (%) 299.99
Particulars MAR 2024 (Values in Cr)
Revenue 755.20
Operating Expense 846.40
Net Profit 31.60
Net Profit Margin (%) 4.18
Earnings Per Share (EPS) 1.99
EBITDA 119.89
Effective Tax Rate (%) 24.22
Particulars MAR 2023 (Values in Cr)
Revenue 774.40
Operating Expense 868.70
Net Profit 49.90
Net Profit Margin (%) 6.44
Earnings Per Share (EPS) 3.13
EBITDA 141.00
Effective Tax Rate (%) 37.07
Particulars MAR 2022 (Values in Cr)
Revenue 701.14
Operating Expense 767.17
Net Profit 80.49
Net Profit Margin (%) 11.47
Earnings Per Share (EPS) 5.05
EBITDA 132.62
Effective Tax Rate (%) 4.99
Particulars MAR 2021 (Values in Cr)
Revenue 2688.07
Operating Expense 2484.21
Net Profit 214.48
Net Profit Margin (%) 7.97
Earnings Per Share (EPS) 13.47
EBITDA 474.94
Effective Tax Rate (%) 21.48
Particulars MAR 2020 (Values in Cr)
Revenue 3095.02
Operating Expense 3012.58
Net Profit 321.14
Net Profit Margin (%) 10.37
Earnings Per Share (EPS) 20.16
EBITDA 542.43
Effective Tax Rate (%) -7.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 343.92
ROE % 0.76
ROCE % 6.37
Total Debt to Total Equity 0.68
EBITDA Margin 14.82
Particulars MAR 2023 (Values in Cr)
Book Value / Share 339.58
ROE % -7.33
ROCE % 3.05
Total Debt to Total Equity 0.64
EBITDA Margin 13.21
Particulars MAR 2022 (Values in Cr)
Book Value / Share 334.10
ROE % 8.21
ROCE % 9.52
Total Debt to Total Equity 0.60
EBITDA Margin 18.88
Particulars MAR 2021 (Values in Cr)
Book Value / Share 297.85
ROE % 16.55
ROCE % 11.86
Total Debt to Total Equity 0.74
EBITDA Margin 23.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 351.78
ROE % 17.25
ROCE % 14.09
Total Debt to Total Equity 0.93
EBITDA Margin 29.67
Particulars MAR 2024 (Values in Cr)
Book Value / Share 149.34
ROE % 1.32
ROCE % 2.57
Total Debt to Total Equity 0.15
EBITDA Margin 15.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 151.86
ROE % 2.70
ROCE % 4.27
Total Debt to Total Equity 0.23
EBITDA Margin 17.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 80.47
ROE % 6.12
ROCE % 6.29
Total Debt to Total Equity 0.39
EBITDA Margin 135.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 80.51
ROE % 11.03
ROCE % 11.58
Total Debt to Total Equity 0.65
EBITDA Margin 17.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 163.67
ROE % 12.98
ROCE % 9.90
Total Debt to Total Equity 0.75
EBITDA Margin 17.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 956.80
Total Assets 11548.50
Total Liabilities 11548.50
Total Equity 5421.10
Share Outstanding 158350737
Price to Book Ratio 3.81
Return on Assets (%) 0.66
Return on Capital (%) 0.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1014.30
Total Assets 11156.70
Total Liabilities 11156.70
Total Equity 5391.80
Share Outstanding 159281139
Price to Book Ratio 1.84
Return on Assets (%) -0.54
Return on Capital (%) -0.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 984.23
Total Assets 9990.86
Total Liabilities 9990.86
Total Equity 5316.40
Share Outstanding 159281139
Price to Book Ratio 4.82
Return on Assets (%) 4.14
Return on Capital (%) 5.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 671.31
Total Assets 8918.11
Total Liabilities 8918.11
Total Equity 4741.51
Share Outstanding 159281139
Price to Book Ratio 8.45
Return on Assets (%) 9.37
Return on Capital (%) 11.41
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1399.87
Total Assets 12521.65
Total Liabilities 12521.65
Total Equity 5603.88
Share Outstanding 159281139
Price to Book Ratio 1.52
Return on Assets (%) 7.17
Return on Capital (%) 8.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 36.10
Total Assets 2991.90
Total Liabilities 2991.90
Total Equity 2374.50
Share Outstanding 159281139
Price to Book Ratio 3.81
Return on Assets (%) 1.05
Return on Capital (%) 1.16
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.00
Total Assets 3008.40
Total Liabilities 3008.40
Total Equity 2414.50
Share Outstanding 159281139
Price to Book Ratio 1.84
Return on Assets (%) 1.65
Return on Capital (%) 1.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 22.50
Total Assets 1829.47
Total Liabilities 1829.47
Total Equity 1281.81
Share Outstanding 159281139
Price to Book Ratio 4.82
Return on Assets (%) 4.29
Return on Capital (%) 4.41
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.32
Total Assets 1844.59
Total Liabilities 1844.59
Total Equity 1282.44
Share Outstanding 159281139
Price to Book Ratio 8.45
Return on Assets (%) 11.62
Return on Capital (%) 12.08
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 257.73
Total Assets 5433.38
Total Liabilities 5433.38
Total Equity 2607.29
Share Outstanding 159281139
Price to Book Ratio 1.52
Return on Assets (%) 5.91
Return on Capital (%) 7.05
Particulars MAR 2024 (Values in Cr)
Net Income 170.50
Cash from Operations 1179.00
Cash from Investing -607.90
Cash from Financing -432.50
Net change in Cash -57.50
Free Cash Flow 2076.70
Particulars MAR 2023 (Values in Cr)
Net Income 27.80
Cash from Operations 865.00
Cash from Investing -544.40
Cash from Financing -156.70
Net change in Cash 30.10
Free Cash Flow 1679.50
Particulars MAR 2022 (Values in Cr)
Net Income 630.44
Cash from Operations 1031.63
Cash from Investing -380.37
Cash from Financing -32.59
Net change in Cash 481.86
Free Cash Flow 1631.62
Particulars MAR 2021 (Values in Cr)
Net Income 1212.01
Cash from Operations 2178.38
Cash from Investing -739.01
Cash from Financing -1709.38
Net change in Cash -651.87
Free Cash Flow 2705.87
Particulars MAR 2020 (Values in Cr)
Net Income 1210.53
Cash from Operations 1791.59
Cash from Investing -327.00
Cash from Financing -1050.37
Net change in Cash 225.41
Free Cash Flow 2365.75
Particulars MAR 2024 (Values in Cr)
Net Income 41.70
Cash from Operations 155.40
Cash from Investing -40.30
Cash from Financing -77.80
Net change in Cash 25.10
Free Cash Flow 223.00
Particulars MAR 2023 (Values in Cr)
Net Income 79.30
Cash from Operations -47.70
Cash from Investing 31.10
Cash from Financing 22.50
Net change in Cash -11.50
Free Cash Flow 11.89
Particulars MAR 2022 (Values in Cr)
Net Income 82.24
Cash from Operations 15.82
Cash from Investing 93.10
Cash from Financing -107.37
Net change in Cash -17.82
Free Cash Flow 17.77
Particulars MAR 2021 (Values in Cr)
Net Income 273.16
Cash from Operations 650.97
Cash from Investing 177.95
Cash from Financing -781.64
Net change in Cash 4.68
Free Cash Flow 743.77
Particulars MAR 2020 (Values in Cr)
Net Income 298.83
Cash from Operations 336.78
Cash from Investing -197.71
Cash from Financing -41.04
Net change in Cash 78.00
Free Cash Flow 534.34
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 33.57 3.18 447.69 37.54 / 77.70
BLISS GVS PHARMA LTD 163.60 20.48 1.70 1722.74 92.25 / 172.40
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.85 141.27 4.12 1197.40 145.00 / 413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 50.80 9.93 447.69 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.60 45.60 7.27 2167.14 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6597.95 128.14 24.28 16494.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.60 21.30 1.68 1722.74 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1202.20
  • 26 Days 1170.00
  • 10 Days 1180.20
  • 50 Days 1174.50
  • 12 Days 1176.00
  • 100 Days 1055.10
  • 20 Days 1192.90
  • 200 Days 635.20
1217.42
PIVOT
First Resistance 1241.73
Second Resistance 1256.82
Third Resistance 1281.13
First Support 1202.33
Second Support 1178.02
Third Support 1162.93
RSI 57.64
MACD 5.98
Commodity Channel Index (CCI) 44.35
ADX 9.86
Williams % R -18.21

Over 1 Month

down

-2.06

Over 3 Months

down

33.77

Over 6 Months

down

82.63

Over 1 Year

down

160.93

Over 3 Years

down

27.08

Over 5 Years

down

23.14

JUBILANT PHARMOVA LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

JUBILANT PHARMOVA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
25.72
Promoter Holdings
50.67
FII
17.94
DII
5.66
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Spb Trustee Company Pvt Ltd Shareholding of Promoter and Promoter Group 3.2686161E7 20.52
Hsb Trustee Company Pvt Ltd Shareholding of Promoter and Promoter Group 3.0257475E7 19.0
East Bridge Capital Master Fund I Ltd Public Shareholding 7773961.0 4.88
Government Pension Fund Global Public Shareholding 5905696.0 3.71
Miller Holdings Pte Ltd Shareholding of Promoter and Promoter Group 5230455.0 3.28
Rekha Jhunjhunwala Public Shareholding 5224000.0 3.28
Rekha Jhunjhunwala Public Shareholding 5020000.0 3.15
Mav Management Advisors Llp Shareholding of Promoter and Promoter Group 5011400.0 3.15
Nikita Resources Private Limited Shareholding of Promoter and Promoter Group 3504540.0 2.2
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 3059145.0 1.92
Jubilant Enpro Private Limited Shareholding of Promoter and Promoter Group 2116000.0 1.33
Theleme India Master Fund Limited Public Shareholding 2114550.0 1.33
Abakkus Emerging Opportunities Fund-1 Public Shareholding 1909849.0 1.2
Priyavrat Bhartia Shareholding of Promoter and Promoter Group 1398010.0 0.88
Hari Shanker Bhartia Shareholding of Promoter and Promoter Group 360885.0 0.23
Shamit Bhartia Shareholding of Promoter and Promoter Group 129245.0 0.08
Kavita Bhartia Shareholding of Promoter and Promoter Group 10285.0 0.01
Jaytee Private Limited Shareholding of Promoter and Promoter Group 7600.0 0.0
Rance Investment Holdings Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Cumin Investments Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Torino Overseas Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Shyam Sunder Bhartia Shareholding of Promoter and Promoter Group 5000.0 0.0
Jubilant Advisors Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Jubilant Consumer Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Vam Holdings Limited Shareholding of Promoter and Promoter Group 0.0 0.0

JUBILANT PHARMOVA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-08-10 5.0 Final 2023-08-10 Equity shares 2022-08-11 5.0 Final 2022-08-12 Equity shares 2021-08-05 5.0 Final 2021-08-06 Equity shares 2020-03-09 5.0 Interim 2020-03-11 Equity shares 2019-09-12 4.5 Final 2019-09-14 Equity shares 2018-09-12 3.0 Final 2018-09-15 Equity shares 2017-08-16 3.0 Final 2017-08-19 Equity shares 2016-08-18 3.0 Final 2016-08-20 Equity shares 2015-08-20 3.0 Final 2015-08-22 Equity shares 2014-08-21 3.0 Final 2014-08-23 Equity shares 2013-08-14 3.0 Final 2013-08-17 Equity shares 2012-08-14 3.0 Final 2012-08-17 Equity shares 2011-08-10 2.0 Final 2011-08-12 Equity shares 2010-09-17 2.0 Final 2010-09-21 Equity shares 2009-06-29 1.5 Final 2009-07-01 Equity shares 2008-09-17 1.5 Final 2008-09-19 Equity shares 2007-09-17 1.25 Final 2007-09-19 Equity shares 2006-09-08 0.0 Final 2006-09-12 Equity shares
Ex-Date Ex-Bonus Ratio
2004-03-15 2004-03-12 3:5
Ex-Date Old FV NEW FV Record Date
2006-03-17 5.0 1.0 2006-03-24 2002-11-12 10.0 5.0 2002-11-21

Learn More About Stocks

About JUBILANT PHARMOVA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by JUBILANT PHARMOVA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Jubilant Pharmova Ltd?

Answer Field

The share price of Jubilant Pharmova Ltd for NSE is ₹ 1227.1 and for BSE is ₹ 1232.35.

What is the Market Cap of Jubilant Pharmova Ltd?

Answer Field

The market cap of Jubilant Pharmova Ltd for NSE is ₹ 1,94,31.22 Cr. and for BSE is ₹ 1,95,14.35 Cr. as of now.

What is the 52 Week High and Low of Jubilant Pharmova Ltd?

Answer Field

The 52 Week High and Low of Jubilant Pharmova Ltd for NSE is ₹ 1309.90 and ₹ 450.80 and for BSE is ₹ 1309.00 and ₹ 451.05.

How to Buy Jubilant Pharmova Ltd share?

Answer Field

You can trade in Jubilant Pharmova Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Jubilant Pharmova Ltd?

Answer Field

The 1 year returns on the stock has been 160.93%.

What is the Current Share Price of Jubilant Pharmova Ltd?

Answer Field

Jubilant Pharmova Ltd share price is for NSE ₹ 1227.1 & for BSE ₹ 1232.35 as on Dec 04 2024 03:30 PM.

What is the Market Cap of Jubilant Pharmova Ltd Share?

Answer Field

The market cap of Jubilant Pharmova Ltd for NSE ₹ 1,94,31.22 & for BSE ₹ 1,95,14.35 as on Dec 04 2024 03:30 PM.

What is the P/E Ratio of Jubilant Pharmova Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM the price-to-earnings (PE) ratio for Jubilant Pharmova Ltd share is 642.15.

What is the PB ratio of Jubilant Pharmova Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM, the price-to-book (PB) ratio for Jubilant Pharmova Ltd share is 144.29.

How to Buy Jubilant Pharmova Ltd Share?

Answer Field

You can trade in Jubilant Pharmova Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jubilant Pharmova Ltd Share on Bajaj Broking App?

Answer Field

To buy Jubilant Pharmova Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jubilant Pharmova Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader